74
Participants
Start Date
December 31, 2007
Study Completion Date
June 30, 2009
rosuvastatin
40 mg, tablet, once daily for 3 months.
placebo
40 mg, tablet, once daily for 3 months
Research Site, Uppsala
Lead Sponsor
AstraZeneca
INDUSTRY